VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44 USD | +1.48% |
|
+2.02% | -11.72% |
| 04-24 | Ventas, Inc. Closes Extended and Improved $2.75 Billion Unsecured Credit Facility | CI |
| 03-18 | Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 | MT |
| Sales 2024 * | 4.8B 6.56B | Sales 2025 * | 5.07B 6.93B | Capitalization | 17.72B 24.22B |
|---|---|---|---|---|---|
| Net income 2024 * | -534M -730M | Net income 2025 * | -262M -358M | EV / Sales 2024 * | 6.45 x |
| Net Debt 2024 * | 13.21B 18.06B | Net Debt 2025 * | 13.23B 18.08B | EV / Sales 2025 * | 6.1 x |
| P/E ratio 2024 * |
-34.1
x | P/E ratio 2025 * |
-56.2
x | Employees | 486 |
| Yield 2024 * |
4.2% | Yield 2025 * |
4.38% | Free-Float | 99.35% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | +1.48% | ||
| 1 week | +2.02% | ||
| Current month | +1.06% | ||
| 1 month | +3.90% | ||
| 3 months | -7.17% | ||
| 6 months | +4.54% | ||
| Current year | -11.72% |
1 week
42.66
44.25
1 month
41.4544.25
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 208 M€ | -.--% | ||
| 1.91% | 285 M€ | -3.89% | ||
| 1.43% | 130 M€ | +0.54% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 44 | +1.48% | 1,899,133 |
| 24-04-25 | 43.36 | -0.57% | 1,162,358 |
| 24-04-24 | 43.61 | +0.11% | 1,490,803 |
| 24-04-23 | 43.56 | +1.00% | 2,605,807 |
| 24-04-22 | 43.13 | 0.00% | 1,434,313 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
44
USD
Average target price
52.47
USD
Spread / Average Target
+19.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.72% | 17.72B | |
| +4.62% | 55.76B | |
| -5.05% | 13.23B | |
| +1.40% | 7.68B | |
| -16.54% | 5.39B | |
| +8.62% | 3.28B | |
| -2.31% | 3.23B | |
| -5.42% | 3.06B | |
| -8.15% | 2.73B | |
| +12.61% | 2.73B |
- Stock Market
- Equities
- VTR Stock
